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Endometrial cancer is the most common 
gynecological malignancy and the fourth most 
common cancer in women.  With accumulating 
evidence, microRNAs have emerged as 
significant players in the development and 
progression of cancers. To investigate the role 
of miRNAs in endometrial cancer, we used 
quantitative real-time PCR arrays to identify 
miRNAs dysregulated in a panel of endometrial 
cancer tissue samples. Out of 667 miRNAs, 
miR-888 was identified as one of the most highly 
over-expressed miRNAs, specifically in mixed 
mϋllerian tumors, arguably the most aggressive 
form of endometrial cancer. Furthermore, real-
time PCR validations revealed a significant 
inverse correlation between age onset of cancer 
and the level of miR-888 expression. Notably, a 
potential target of miR-888 is the progesterone 
receptor, whose role in endometrial cancer is 
well characterized. Together, these data point to 
miR-888 playing an important functional role in 
the development of aggressive endometrial 
tumors. Future research will focus on identifying 
and validating the targets of miR-888 to 
elucidate its mechanism of action and support 
this hypothesis.  
 
